在risperidone研究中，29%的有胃肠道疾病历史，而在methylphenidate研究中只有14%。

In the risperidone study, 29 percent had a history of GI problems compared to 14 percent in the methylphenidate study.

youdao

在risperidone研究中，29%的有胃肠道疾病历史，而在methylphenidate研究中只有14%。

In the risperidone study, 29 percent had a history of GI problems compared to 14 percent in the methylphenidate study.

youdao